1887

Hedgehogs (Erinaceus europaeus)

Drug Dose Comments
  • Gaseous anaesthesia alone can be used in hedgehogs
Alfaxalone
  • 2–6 mg/kg i.m.
  • In combination with dexmedetomidine for sedation: Alfaxalone (2 mg/kg) + dexmedetomidine (0.05 mg/kg) i.m.
  • In combination with midazolam for deep sedation to light anaesthesia: Alfaxalone (3—5 mg/kg) + midazolam (1 mg/kg) deep s.c.
  • Gaseous anaesthesia can then be used for maintenance if required
  • Reverse dexmedetomidine with atipamezole (see below)
  • Higher doses of alfaxalone will induce light anaesthesia. Midazolam can be reversed with flumazenil 0.05 mg/kg s.c.
Diazepam
  • Sedation: 0.5–2 mg/kg i.m.
  • Anticonvulsant: 3 mg/kg i.m.
  • In combination with ketamine for anaesthesia: Diazepam (0.5—2 mg/kg) + ketamine (5–20 mg/kg) i.m.,
 
Ketamine
  • 10–20 mg/kg i.m.
  • In combination with diazepam for anaesthesia see above
  • In combination with medetomidine for anaesthesia: Ketamine (5 mg/kg) + medetomidine (0.1 mg/kg) i.m.
  • Sole agent – variable effects; prolonged recovery seen in some cases
Medetomidine
  • 0.05–0.1 mg/kg i.m. for light sedation; 0.2 mg/kg i.m. for deep sedation
  • In combination with ketamine for anaesthesia see above
  • Variable effects; prolonged recovery seen in some cases
  • Reverse with atipamezole (see below)
Atipamezole
  • 0.25—0.5 mg/kg i.m., s.c. (equivalent to 5x dose (mg/kg) medetomidine or 10x dose (mg/kg) dexmedetomidine used)

    Note: Doses up to 1 mg/kg i.m. are quoted by some authors for use in European hedgehogs
  • Reversal of medetomidine: 5 times the medetomidine dose (i.e. equal volume of the 5 mg/ml atipamezole solution)
  • Reversal of dexmedetomidine: 10 times the dexmedetomidine dose (0.5 mg/ml solution) (i.e. equal volume of the 5 mg/ml atipamezole solution when 0.5 mg/ml solution of dexmedetomidine is used)
Buprenorphine
  • 0.02–0.05 mg/kg i.m., s.c. q6–8h
  • Opioid analgesics for moderate/severe pain
Butorphanol
  • 0.2–0.4 mg/kg i.m., s.c. q6–8h
Carprofen
  • 5–10 mg/kg s.c. q24h; p.o. q12h
  • Note these doses are higher than those suggested by other authors in other hedgehog species but are commonly used in European hedgehogs
  • Anti-inflammatory: the usual considerations for the careful use of NSAIDs in dehydrated, hypovolaemic or hypertensive animals, as well as those with underlying gastrointestinal disease, should be observed
Meloxicam
  • 0.5 mg/kg s.c., p.o. q24h
  • Antibiotic use (both appropriate and inappropriate) imposes a powerful selection pressure on bacteria and is the primary driver of antibiotic resistance. Eliminating unnecessary use in people and animals is, therefore, essential to safeguard this invaluable resource. Prudent use is especially indicated where treated wild animals are being returned to the wild. The reader is referred to the Guide for the Responsible Use of Antibiotic, for further information (https://www.bsavalibrary.com/content/formulary/backmatter/exotic-petsguidelinesforresponsibleantibacterialuse)
Amoxicillin/clavulanate (co-amoxiclav)
  • 30–50 mg/kg i.m., s.c. q24h, p.o. q12h
  • Broad-spectrum bactericidal
  • Useful for infections of the respiratory tract, skin and soft tissues (including abscesses)
  • Note these doses are higher than those suggested by other authors in other hedgehog species but are commonly used in European hedgehogs
Amoxicillin LA
  • 50–150 mg/kg s.c. q24h or q48h
  • Broad-spectrum bactericidal administered every 48 hours for infections (e.g. for secondary bacterial pneumonia associated with lungworm)
  • Higher doses (up to 150 mg/kg) and increased frequency (q24h) may, anecdotally, be effective for more severe infections
Cefalexin
  • 25 mg/kg p.o. q8h
  • 30 mg/kg i.m., s.c., p.o. q12–24h
  • Cephalosporins should ideally be reserved for infections where culture and sensitivity testing predict a clinical response and use of first- and second-line antimicrobials would not be considered effective
  • Anecdotally, dosing q24h i.m. or s.c. dosing may be effective for most soft tissue infections, but more severe infections (e.g. abscesses and pyoderma) require more frequent dosing
Clindamycin
  • 10–20 mg/kg p.o. q12h
  • For anaerobic infections (e.g. abscesses, wound infections and dental infections)
  • May also be useful for infections involving the bones and joints
Enrofloxacin
  • 10–20 mg/kg i.m., s.c., p.o. q12h
  • Fluroquinolones should ideally be reserved for infections where culture and sensitivity testing predict a clinical response and use of first- and second- line antimicrobials would not be considered effective
  • Avoid use in young growing animals as potentially causes abnormalities of the cartilage
Marbofloxacin
  • 8–10 mg/kg s.c. q24h
Metronidazole
  • 20–40 mg/kg p.o. q12h
  • For anaerobic infections
Oxytetracycline
  • 50 mg/kg i.m., s.c., p.o. q12h
  • Broad-spectrum bacteriostatic
Enilconazole
  • 0.2% dilution applied topically every 3 days for 4–6 applications
  • Topical antifungal treatment for ringworm applied as a wash or spray
  • May be used as a sole agent in mild cases and concurrently with systemic antifungals in severe cases
  • After treatment, keep hedgehogs warm to prevent hypothermia, especially in small juveniles
Itraconazole
  • 10–15 mg/kg p.o. q12h
  • Parenteral antifungal treatment for ringworm
  • Treat for 2–4 weeks and then re-sample
Terbinafine
  • 50–100 mg/kg p.o. q12h or q24h
  • Parenteral antifungal treatment for ringworm
  • Appears to be more effective than itraconazole
  • Treat for 2–4 weeks and then re-sample
  • Suggested dosing frequency is q12h but, anecdotally, it is as effective when administered q24h (especially in larger animals)
  • Parasiticide use in wildlife may reduce the development of natural resistance to parasites, as well as exerting selection pressure on organisms which can lead to drug resistance, and may risk environmental contamination. Careful selection and use of these drugs, only where there is a clinical need, and then using narrow spectrum products, is essential where treated wild animals are being returned to the wild. Reader is referred to the joint BVA, BSAVA and BVZS policy statement
Cyromazine
  • Topical application to wet the affected area
  • Insect growth inhibitor useful for preventing hatching and development of blowfly larvae
  • Can be used in combination with an insecticide to kill existing maggots
  • Easy to apply, especially between the spines, if used as a spray, be aware of the cooling affect – do not use in hypothermic animals
Febendazole
  • 100 mg/kg p.o. q24h for 5-7 days
  • Useful as an in-feed treatment against nematodes and may have some effect on cestodes
  • Has been used for 7 days to treat spp. In wild Northern White-Breasted hedgehogs ()
Fipronil
  • 0.25% spray used sparingly
  • 7.5–15 mg/kg spot-on application
  • Useful for treating fleas and ticks
  • Always ensure good ventilation during and after treatment
  • Be aware of the cooling affect – do not use in hypothermic animals
Ivermectin (injectable)
  • 0.2–0.5 mg/kg s.c. for most endo and ectoparasites
  • 3.0–5.0 mg/kg s.c. for lungworm infections
  • Good activity against most parasites: lower doses typically used for ectoparasites; higher doses used for treatment of lungworm in European hedgehogs
  • Repeat treatment every 7–10 days if necessary
Ivermectin (topical)
  • 0.2–0.5 mg/kg spot-on application
  • Useful for treating ectoparasites (e.g. fleas, ticks and mites)
  • Repeat treatment after 10 days
Levamisole
  • 27 mg/kg s.c. q48h
  • 35 mg/kg p.o q24 for 2 days
  • Dosing regimen for injectable product: 3 injections given at 48-hour intervals (other regimes have been described)
  • Dosing regimen for oral product: 2 doses given at a 24hr interval(other regimes have been described)
  • Lower doses (10—20 mg/kg) are suggested in other hedgehog species as therapeutic margin or safety can be low
  • Traditionally used for lungworm treatment but drug availability in the UK may be a problem, so often replaced by ivermectin
Mebendazole
  • 50–100 mg/kg p.o. q24h for 5 days
  • Useful for treating nematodes and cestodes
Moxidectin (injectable)
  • 5 mg/kg s.c. for lungworm infections
  • Less effective than ivermectin in both injectable and spot-on forms
Moxidectin (topical)
  • 2 mg/kg topical (given as 0.2 ml/kg 1% moxidectin and 10% imidacloprid spot-on product)
  • The inclusion of imidocloprid in the spot-on product raises concerns regarding environmental contamination this together with the recorded poor efficacy means there is little justification for use of combination moxidectin products
Praziquantel
  • 10–20 mg/kg p.o. once
  • 30 mg/kg spot-on application
Useful for treating cestodes and trematodes
Sulfadimidine
  • 200 mg/kg s.c. q24h for 3 days
Useful for treating coccidiosis
Sulfadoxine/trimethoprim
  • 50 mg/kg i.m., s.c. q24h for 5 days
  • 30 mg/kg i.m., s.c., p.o. q12
Toltrazuril
  • 25–50 mg/kg p.o.; repeat if necessary
Bromhexine
  • 1 pinch of powder p.o. q12h (3 mg/kg q24h)
  • Mucolytic
  • Aids expectoration of mucus in parasitic bronchopneumonia
Clenbuterol
  • 1 pinch of granules p.o. q12h
  • Bronchodilator
  • Relieves bronchospasm and assists mucociliary clearance in respiratory disease
Dexamethasone
  • 1–5 mg/kg i.v., i.m., s.c.
  • Corticosteroid: lower doses are anti-inflammatory; higher doses may be useful in treating parasitic bronchopneumonia but are likely to be immunosupressive
  • Corticosteriods should be used with caution, especially in wild animals
NSAID(s) = non-steroidal anti-inflammatory drugs

Bellini L, Pagani G, Mollo A et al.(2019) Evaluation of alfaxalone and dexmedetomidine for intramuscular restraint in European hedgehogs (). 185(5), 145

Bexton S (2016) Hedgehogs. , 2 edition, ed. E Mullineaux and E Keeble, pp. 117–136. BSAVA Publications, Gloucester

Carpenter JW and Harms CA (2022) . Elsevier, Oxford

Bexton S and Nelson H (2016) Comparison of two systemic antifungal agents, itraconazole and terbinafine, for the treatment of dermatophytosis in European hedgehogs (). 27(6), 500–e133

Alfaia F, Jota Baptista C, Lozano J et al. (2024) Efficacy of a new fenbendazole treatment protocol against spp. in northern, white-breasted Hedgehog (). 4, 270–278

Van de Weyer Y, Santos MC, Williams N et al. (2023) Efficacy of levamisole, ivermectin and moxidectin against spp. in European hedgehogs (). , 97(e99), 1–9

Barutzki D, Laubmeier E and Forstner MJ (1987) Endoparasitic infestation of wild hedgehogs and hedgehogs in human care with a contribution to therapy. , 15(3), 325–331

Bexton S and Couper D (2019) Veterinary care of free-living hedgehogs. 41(9), 420–432

BSAVA Library https://www.bsavalibrary.com/

BVA, BSAVA, BVZS joint policy statement: Responsible use of parasiticides https://www.bva.co.uk/take-action/our-policies/responsible-use-of-parasiticides-for-cats-and-dogs/

The British Hedgehog Preservation Society https://www.britishhedgehogs.org.uk

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error